34 hospitals, 431 pharma stores suspended from RGHS for fraud in three months

Jaipur:  The health department Friday reported major action against irregularities in the Rajasthan Govt Health Scheme (RGHS), suspending 34 hospitals and 431 pharma stores over the past three months. The department also suspended 28 govt employees and registered 17 FIRs for misuse of the scheme.

Officials said multiple complaints were received about hospitals, medical stores and govt employees engaging in fraudulent practices that harmed the scheme’s functioning. A special audit and intensive investigation were conducted, following which strict action was taken against all entities found prima facie guilty.

An Anti-Fraud Cell has now been set up to curb future violations, and a new SOP will soon be issued to strengthen monitoring, health minister Gajendra Singh Khimsar said.

According to the report, the RGHS office increased surveillance in recent months to protect the treasury and ensure smooth functioning of the scheme. During this period, cases surfaced of private hospitals, approved pharma stores and even beneficiaries availing benefits through improper and rule-violating methods, causing substantial financial losses.

Principal secretary (health) Gayatri Rathore said 34 hospitals were suspended after being found involved in practices such as raising double claims for a single surgery, conducting unnecessary tests and billing higher-rate test packages instead of lower-rate available options. Penalties amounting to Rs 36 crore have been recovered from these hospitals so far.

Similarly, 431 pharma stores were suspended for issuing fake bills and misusing RGHS benefits through collusion between pharmacists, doctors and beneficiaries. The department recovered Rs 4.6 crore in penalties in these cases. More than 1,000 RGHS beneficiary cards used in fraudulent claims have also been blocked, while 28 employees involved in misuse have been suspended.

Related Posts

PGIMS recalls drug amid probe into deaths

The PGIMS authorities have directed all departments to immediately stop using a specific batch of injectable Propofol, an anaesthetic drug, and return the available stock to the central store. The…

NPPA list brings little relief: No price cut for 25% cancer drugs

Mumbai: Nearly one in four cancer drug packs in a revised price list issued by the National Pharmaceutical Pricing Authority (NPPA) has seen no reduction in maximum retail price (MRP),…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

PGIMS recalls drug amid probe into deaths

PGIMS recalls drug amid probe into deaths

NPPA list brings little relief: No price cut for 25% cancer drugs

NPPA list brings little relief: No price cut for 25% cancer drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

For Aakash Healthcare, Community People are Apples of its Eyes

For Aakash Healthcare, Community People are Apples of its Eyes

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Yashoda Medicity: Baby takes a Giant Step in just One Year

Yashoda Medicity: Baby takes a Giant Step in just One Year